Company · CIK 0001906324 · SIC 2835 — In Vitro & In Vivo Diagnostic Substances · Nasdaq
QuidelOrtho Corp · QDEL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 FMForm 4 → | Sep 17, 6:32 pm EDT | Ronald Lee BowmanChief Human Resources Officer | 3,487 | $10.63 | $9,790 | 5,020 | — | |
| Aug 15, 2026 FMForm 4 → | Aug 18, 4:14 pm EDT | Bryan Michael HansonEVP Global Port. Mgmt & Mkting | 608 | $14.30 | $2,317 | 8,055 | — | |
| Jul 1, 2026 FMForm 4 → | Jul 2, 4:06 pm EDT | Bryan Michael HansonEVP Global Port. Mgmt & Mkting | 7,893 | $18.18 | $38,105 | 7,771 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 17, 6:32 pm EDT | Ronald Lee BowmanChief Human Resources Officer | 2,566 | — | — | 2,566 | — | |
| Aug 15, 2026 MForm 4 → | Aug 18, 4:14 pm EDT | Bryan Michael HansonEVP Global Port. Mgmt & Mkting | 446 | — | — | 0 | — | |
| Jul 15, 2026 AForm 4 → | Jul 16, 4:20 pm EDT | Micah W YoungChief Financial Officer | 356,555 | — | — | 356,555 | — | |
| Jul 1, 2026 MForm 4 → | Jul 2, 4:06 pm EDT | Bryan Michael HansonEVP Global Port. Mgmt & Mkting | 5,797 | — | — | 11,595 | — |